URGO URGOSTART BORDER 8 CM X 8 CM

Descriptions
Urgo UrgoStart Border 8 cm x 8 cm is indicated for the treatment of exudative wounds: chronic wounds (pressure sores, leg ulcers, diabetic foot wounds) and acute chronic wounds.

Urgo UrgoStart Border is a hydrocellular adhesive absorbent lipido-colloid dressing with micro-adherent TLC-NOSF matrix, an innovative technology developed by Urgo Laboratories.

- a micro-adherent TLC-NOSF matrix, combined with an absorbent polyurethane foam and a super-absorbent layer.
- an impermeable outer support (but allowing gas exchange) coated with an adhesive silicone layer.
This specific combination is a patented structure.

The properties of UrgoStart Border are therefore multiple:
- accelerated wound healing. - highly conformable and easy to reposition.

Directions for use
Carefully read the instructions before use.
- Preparing the wound: Clean the wound according to the usual care protocol. If an antiseptic has previously been used, rinse the wound thoroughly with saline before applying UrgoStart Border. Carefully dry the peri-injured skin.

- Applying the plaster: Remove the protective wings. Apply the central micro-adherent compress of UrgoStart Border opposite the wound (the adhesive silicone edges must be at least 1 cm from the wound). Smooth the plaster over the wound. Apply a compression bandage to the plaster when prescribed.

- Removing the plaster: By pressing on the healthy skin, lift one corner of the plaster and gently remove it.

- Renewing the plaster : The UrgoStart Border plaster should be renewed every 2 to 4 days, and up to 7 days depending on the volume of exudate and the clinical condition of the wound. The recommended treatment period is a minimum of 8 weeks.

Precautions for use
Including a super-absorbent layer, the central compress must not be cut. However, the silicone adhesive edges can be cut with sterile material to conform to different anatomical contours. If the wound shows signs of significant bacterial colonisation, it is advisable to first treat the bacterial component before initiating treatment with UrgoStart Border. In the case of an atypical ulcer showing induration or excessive budding, treatment with UrgoStart Border should only be initiated after checking that the ulcer is not degenerating, so as not to delay diagnosis. Possible tingling or even painful sensations have been reported mainly at the beginning of treatment with UrgoStart Border. These are related to the resumption of the scarring process and rarely justify suspension of treatment. In the absence of clinical data in acute uncomplicated wounds and in Epidermolysis Bullosa (however old), the use of UrgoStart Border is not recommended. Cut excess hair as close to the skin as possible to ensure good contact with the wound. Cut excess hair as close to the skin as possible to ensure good contact with the wound. If used in conjunction with a cream, ointment, ointment or emulsion, allow the skin to dry before applying the plaster. UrgoStart Border must not be used in hyperbaric chambers. Single-use sterile packaging: re-use of a single-use plaster may lead to a risk of infection. Do not re-sterilise the plaster. Check the integrity of the sterility protector before use. Do not use if packaging is damaged.

Contra-indications
At the risk of delaying appropriate management, UrgoStart Border is contraindicated in cancerous wounds and fistulous wounds revealing deep abscessation. Do not use UrgoStart Border in cases of known sensitivity to the plaster.

Composition
carboxymethylcellulose, vaseline, paraffin, antioxidant, cohesion polymer, wetting agent, micronised oligosaccharide (NOSF).

Packaging
16 plasters.